Evotec Competitors and Similar CompaniesClear all
Evotec's competitors and similar companies include Eurofins, WuXi Biologics, Actelion Pharmaceuticals and Catalent.
 WuXi Biologics WuXi Biologics (药明生物) is a company operating as an open-access technology platform for biologics drug development. |  Actelion Pharmaceuticals Actelion Pharmaceuticals is a biopharmaceutical company focusing on the discovery, development, and commercialization of innovative treatments to serve high unmet medical needs. |  Catalent Catalent is a company that develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, vaccines, and consumer health products. | |||
Founding Date | Founding Date 1993 | Founding Date 1987 | Founding Date 2010 | Founding Date 1997 | Founding Date 2007 |
Type | Type Public | Type Public | Type Public | Type Subsidiary | Type Subsidiary |
Tags | |||||
Locations | Locations Hamburg, DE HQ Lyon, FR Toulouse, FR Göttingen, DE Halle (Westfalen), DE Köln, DE Munich, DE see more | Locations Wuxi, CN HQ George Town, KY Wuppertal, DE Hong Kong, HK Dundalk, IE Cranbury, US King Of Prussia, US | Locations Bridgewater, US HQ Buenos Aires, AR Bruxelles, BE Charleroi, BE Charleroi, BE Charleroi, BE Indaiatuba, BR see more | ||
Employees | Employees 4,766 | Employees 65,0004% increase | Employees 12,575 | Employees 51712% decrease | Employees 12,6955% increase |
Valuation ($) | Valuation ($) 1.4 b | Valuation ($) 9.5 b | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) €788.4m (FY, 2025) | Revenue (est.) €7.3b (FY, 2025) | Revenue (est.) ¥21.8b (FY, 2025) | Revenue (est.) N/A | Revenue (est.) $4.4b (FY, 2024) |
Cost of goods | Cost of goods €622.9m (FY, 2025) | Cost of goods €2.3b (FY, 2025) | Cost of goods ¥10b (FY, 2025) | Cost of goods N/A | Cost of goods $3.4b (FY, 2024) |
Gross profit | Gross profit €231.1m (FY, 2025) | Gross profit €5b (FY, 2025) | Gross profit ¥12b (FY, 2025) | Gross profit N/A | Gross profit $953m (FY, 2024) |
Net income | Net income (€103.5m) (FY, 2025) | Net income €473m (FY, 2025) | Net income ¥5.7b (FY, 2025) | Net income N/A | Net income ($1b) (FY, 2024) |
Operating ⚠ | |||||
Backlog | Backlog N/A | Backlog N/A | Backlog $18.5b (H1, 2022) | Backlog N/A | Backlog $2.5b (FY, 2023) |
Countries | Countries N/A | Countries 62 (FY, 2023) | Countries N/A | Countries N/A | Countries 80 (FY, 2023) |
Customers | Customers 781 (FY, 2023) | Customers N/A | Customers N/A | Customers N/A | Customers 1.2 k (FY, 2023) |
Products | Products 140 (FY, 2023) | Products N/A | Products N/A | Products N/A | Products 8 k (FY, 2023) |
Funding | |||||
Total funding raised | Total funding raised $ 993.6m | Total funding raised $ 30m | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 650m |
For sources of this data, please see the company profile
View Company Profiles
Eurofins
HQ
Luxembourg, LU
Employees
65,000↑ 4% increase
Eurofins Scientific is a life sciences company providing laboratory services.
View companyWuXi Biologics
HQ
Wuxi, CN
Employees
12,575
WuXi Biologics (药明生物) is a company operating as an open-access technology platform for biologics drug development.
View companyActelion Pharmaceuticals
HQ
Allschwil, CH
Actelion Pharmaceuticals is a biopharmaceutical company focusing on the discovery, development, and commercialization of innovative treatments to serve high unmet medical needs.
View companyCatalent
HQ
Bridgewater, US
Catalent is a company that develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, vaccines, and consumer health products.
View company